{
  "success": true,
  "pagesUsed": [],
  "modelUsed": "unknown",
  "metadata": {
    "studyName": "A Phase 2, Open-label Study to Assess Copper and Molybdenum Balance in Participants with Wilson Dise",
    "titles": [
      {
        "id": "title_1",
        "text": "A Phase 2, Open-label Study to Assess Copper and Molybdenum Balance in Participants with Wilson Disease Treated with ALXN1840",
        "type": {
          "code": "Official Study Title",
          "codeSystem": "USDM",
          "decode": "Official Study Title"
        },
        "instanceType": "StudyTitle"
      },
      {
        "id": "title_2",
        "text": "Copper and Molybdenum Balance in Participants with Wilson Disease Treated with ALXN1840",
        "type": {
          "code": "Brief Study Title",
          "codeSystem": "USDM",
          "decode": "Brief Study Title"
        },
        "instanceType": "StudyTitle"
      }
    ],
    "identifiers": [
      {
        "id": "sid_1",
        "text": "NCT04573309",
        "scopeId": "org_3",
        "instanceType": "StudyIdentifier",
        "identifierType": {
          "code": "NCT",
          "codeSystem": "USDM",
          "decode": "ClinicalTrials.gov Identifier"
        }
      },
      {
        "id": "sid_2",
        "text": "ALXN1840-WD-204",
        "scopeId": "org_1",
        "instanceType": "StudyIdentifier",
        "identifierType": {
          "code": "SponsorProtocolNumber",
          "codeSystem": "USDM",
          "decode": "Sponsor Protocol Number"
        }
      },
      {
        "id": "sid_3",
        "text": "2020-001104-41",
        "scopeId": "org_eudract",
        "instanceType": "StudyIdentifier",
        "identifierType": {
          "code": "EudraCT",
          "codeSystem": "USDM",
          "decode": "EudraCT Number"
        }
      },
      {
        "id": "sid_4",
        "text": "119006",
        "scopeId": "org_unknown",
        "instanceType": "StudyIdentifier",
        "identifierType": {
          "code": "IND",
          "codeSystem": "USDM",
          "decode": "FDA IND Number"
        }
      }
    ],
    "organizations": [
      {
        "id": "org_1",
        "name": "Alexion Pharmaceuticals, Inc.",
        "type": {
          "id": "b7f54060-b302-44b3-8603-002c6d9ba690",
          "code": "C54086",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Pharmaceutical Company",
          "instanceType": "Code"
        },
        "identifier": "Alexion Pharmaceuticals, Inc.",
        "identifierScheme": "DUNS",
        "instanceType": "Organization"
      },
      {
        "id": "org_2",
        "name": "US Food and Drug Administration",
        "type": {
          "id": "2bd3d5eb-fe95-49db-8db5-578b5697806b",
          "code": "C25461",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Regulatory Agency",
          "instanceType": "Code"
        },
        "identifier": "US Food and Drug Administration",
        "identifierScheme": "DUNS",
        "instanceType": "Organization"
      },
      {
        "id": "org_3",
        "name": "ClinicalTrials.gov",
        "type": {
          "id": "326fbaf8-b90d-4c6c-81fb-20a7375359b3",
          "code": "C19326",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Healthcare Facility",
          "instanceType": "Code"
        },
        "identifier": "ClinicalTrials.gov",
        "identifierScheme": "DUNS",
        "instanceType": "Organization"
      }
    ],
    "roles": [
      {
        "id": "role_1",
        "name": "Sponsor",
        "code": {
          "code": "Sponsor",
          "codeSystem": "USDM",
          "decode": "Sponsor"
        },
        "organizationIds": [
          "org_1"
        ],
        "instanceType": "StudyRole"
      },
      {
        "id": "role_2",
        "name": "Regulatory Authority",
        "code": {
          "code": "Regulatory Agency",
          "codeSystem": "USDM",
          "decode": "Regulatory Agency"
        },
        "organizationIds": [
          "org_2"
        ],
        "instanceType": "StudyRole"
      },
      {
        "id": "role_3",
        "name": "Registry",
        "code": {
          "code": "Sponsor",
          "codeSystem": "USDM",
          "decode": "Sponsor"
        },
        "organizationIds": [
          "org_3"
        ],
        "instanceType": "StudyRole"
      }
    ],
    "indications": [
      {
        "id": "ind_1",
        "name": "Wilson Disease",
        "isRareDisease": false,
        "instanceType": "Indication",
        "description": "Participants with Wilson Disease treated with ALXN1840"
      }
    ],
    "studyPhase": {
      "code": "Phase2",
      "codeSystem": "USDM",
      "decode": "Phase2"
    },
    "studyType": "Interventional"
  },
  "confidence": 1.0
}